Published in Transplant Proc on March 01, 1977
Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus. J Clin Invest (2004) 1.50
Autologous islet transplantation to prevent diabetes after pancreatic resection. Ann Surg (1995) 1.37
One hundred pancreas transplants at a single institution. Ann Surg (1984) 1.20
Transplantation for type I diabetes: comparison of vascularized whole-organ pancreas with isolated pancreatic islets. Ann Surg (2004) 1.15
Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges. Diabetes Metab Syndr Obes (2014) 1.11
Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcome. Rev Diabet Stud (2012) 0.99
Autotransplantation of pancreatic fragments to the portal vein and spleen of totally pancreatectomized dogs: a comparative evaluation. Ann Surg (1978) 0.98
Recent experience with 89 pancreas transplants at a single institution. Diabetologia (1984) 0.96
Pancreatic islet cell therapy for type I diabetes: understanding the effects of glucose stimulation on islets in order to produce better islets for transplantation. J Transl Med (2007) 0.94
Islet Xeno/transplantation and the risk of contagion: local responses from Canada and Australia to an emerging global technoscience. Life Sci Soc Policy (2015) 0.91
Improvement of pancreatic islet cell isolation for transplantation. Proc (Bayl Univ Med Cent) (2007) 0.89
Transplantation for the treatment of type 1 diabetes. World J Gastroenterol (2007) 0.85
Total pancreatectomy with islet autotransplantation: summary of a National Institute of Diabetes and Digestive and Kidney diseases workshop. Pancreas (2014) 0.84
Transplantation of insulin-secreting tissues. Gut (1977) 0.84
Thrombosis and inflammation in intraportal islet transplantation: a review of pathophysiology and emerging therapeutics. J Diabetes Sci Technol (2008) 0.82
Total pancreatectomy with islet autotransplantation: summary of an NIDDK workshop. Ann Surg (2015) 0.82
Assessment of islet function following islet and pancreas transplantation. Curr Diab Rep (2006) 0.81
Recent progress in pancreatic islet transplantation. World J Transplant (2011) 0.81
Update on islet cell transplantation for type 1 diabetes. Semin Intervent Radiol (2012) 0.80
Responses of canine lymphocytes to allogeneic and autologous Islets of Langerhans in mixed cell cultures. J Clin Invest (1981) 0.80
Islet transplantation in genetically determined diabetes. Ann Surg (1977) 0.80
Re-engineering islet cell transplantation. Pharmacol Res (2015) 0.79
Mesobiliverdin IXα Enhances Rat Pancreatic Islet Yield and Function. Front Pharmacol (2013) 0.78
Pancreas transplantation--registry report and a commentary. West J Med (1985) 0.77
Islet cell transplant: Update on current clinical trials. Curr Transplant Rep (2016) 0.75
Single-donor islet transplantation in type 1 diabetes: patient selection and special considerations. Diabetes Metab Syndr Obes (2017) 0.75
Sericin in the isolating solution improves the yield of islets isolated from the pancreas. Cytotechnology (2016) 0.75
Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. J Immunol (1975) 8.06
Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer (1979) 5.60
Structural-functional relationships in diabetic nephropathy. J Clin Invest (1984) 4.78
Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med (1989) 4.40
Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med (1998) 4.30
Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet (1995) 4.06
20 years or more of follow-up of living kidney donors. Lancet (1992) 3.88
Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science (1992) 3.80
Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J Exp Med (1992) 3.42
Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation. Medicine (Baltimore) (1980) 3.42
Limiting financial disincentives in live organ donation: a rational solution to the kidney shortage. Am J Transplant (2006) 3.31
Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci U S A (1993) 3.24
Use of medical emergency team responses to reduce hospital cardiopulmonary arrests. Qual Saf Health Care (2004) 3.00
A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med (1989) 2.78
Surgically induced leukocytic infiltrates within the rat intestinal muscularis mediate postoperative ileus. Gastroenterology (1999) 2.75
Pregnancy outcomes after kidney donation. Am J Transplant (2009) 2.66
Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery (1967) 2.49
Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells. J Exp Med (1989) 2.49
Transplantation of stomach, intestine, and pancreas: experimental and clinical observations. Surgery (1967) 2.49
Immunodepression after major surgery in normal patients. Surgery (1975) 2.48
Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci U S A (1993) 2.46
Pancreatico-duodenal allotransplantation: experimental and clinical experience. Ann Surg (1970) 2.44
Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med (1982) 2.44
Organ donation in three major American cities with large Latino and black populations. Transplantation (1988) 2.41
The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation (1987) 2.40
Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation (1985) 2.34
Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med (1990) 2.32
An L-arginine-dependent mechanism mediates Kupffer cell inhibition of hepatocyte protein synthesis in vitro. J Exp Med (1989) 2.27
Immunologic and nonimmunologic factors: different risks for cadaver and living donor transplantation. Transplantation (2000) 2.25
Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res (1981) 2.25
Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg (1991) 2.24
Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria. N Engl J Med (1989) 2.21
Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection. Hepatology (1985) 2.18
Proposed mechanisms for the translocation of intestinal bacteria. Rev Infect Dis (1988) 2.16
A mammalian equivalent of the avian bursa of Fabricius. Lancet (1966) 2.11
Modulation of nitrogen oxide synthesis in vivo: NG-monomethyl-L-arginine inhibits endotoxin-induced nitrate/nitrate biosynthesis while promoting hepatic damage. J Leukoc Biol (1990) 2.11
Long-term effects of pancreatic transplantation on diabetic neuropathy. Ann Neurol (1997) 2.09
Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol (1991) 2.07
Development of "autoimmune processes" in rabbits after neonatal removal of central lymphoid tissue. Lancet (1965) 2.04
Chemiluminescence response of phagocytizing human monocytes. Infect Immun (1976) 2.01
Surgical manipulation of the gut elicits an intestinal muscularis inflammatory response resulting in postsurgical ileus. Ann Surg (1998) 2.00
American Society of Transplant Surgeons transplant center outcomes requirements--a threat to innovation. Am J Transplant (2009) 2.00
Transplantation of discordant xenografts: a review of progress. Immunol Today (1990) 2.00
Risk factors for chronic rejection in renal allograft recipients. Transplantation (1993) 1.90
Baseline analysis of renal function in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group [corrected]. Kidney Int (1993) 1.90
Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg (2001) 1.89
Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in humans. N Engl J Med (1987) 1.87
Cytomegalovirus-induced immune suppression. I. Humoral immunity. Clin Exp Immunol (1974) 1.86
Association of renal allograft rejection with virus infections. Am J Med (1974) 1.83
Vascular graft thrombosis after pancreatic transplantation: univariate and multivariate operative and nonoperative risk factor analysis. J Am Coll Surg (1996) 1.83
Pancreatic trauma: a review. Surgery (1972) 1.81
Antiserum to lymphocytes: prolonged survival of canine renal allografts. Science (1966) 1.81
Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest (1985) 1.80
Increased incidence of malignancy during chronic renal failure. Lancet (1975) 1.79
The surgical risk of pancreas transplantation in the cyclosporine era: an overview. J Am Coll Surg (1997) 1.79
Family tension in the search for a kidney donor. JAMA (1971) 1.77
Chemiluminescence response of human leukocytes: influence of medium components on light production. Infect Immun (1977) 1.77
Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine. J Immunol (1990) 1.76
Intra-abdominal fungal infections after pancreatic transplantation: incidence, treatment, and outcome. J Am Coll Surg (1996) 1.75
Studies of the rate of regression of the glomerular lesions in diabetic rats treated with pancreatic islet transplantation. Diabetes (1975) 1.74
Preserved insulin secretion and insulin independence in recipients of islet autografts. N Engl J Med (1992) 1.74
Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis. Ann Surg (1990) 1.74
Are wound complications after a kidney transplant more common with modern immunosuppression? Transplantation (2001) 1.73
Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter. Proc Natl Acad Sci U S A (1996) 1.71
Recurrence of idiopathic nephrotic syndrome after renal transplantation. Lancet (1972) 1.71
Effects of pancreas transplantation on glomerular structure in insulin-dependent diabetic patients with their own kidneys. Lancet (1993) 1.70
Reactive nitrogen intermediates suppress the primary immunologic response to Listeria. J Immunol (1993) 1.69
Role of inducible nitric oxide synthase in postoperative intestinal smooth muscle dysfunction in rodents. Gastroenterology (2000) 1.69
Inducible cytosolic enzyme activity for the production of nitrogen oxides from L-arginine in hepatocytes. Biochem Biophys Res Commun (1990) 1.67
Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis. Transplantation (1995) 1.65
Hepatocellular transplantation for metabolic deficiencies: decrease of plasms bilirubin in Gunn rats. Science (1976) 1.65